United States
# |
Name |
EPS (Diluted) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 119.47
|
Sept. 30, 2024 | USD 12.72 | -6.33% |
|
United States |
|
2 |
USD 40.41
|
Sept. 30, 2024 | USD 666.85 | -0.91% |
|
United States |
|
3 |
USD 31.25
|
Sept. 30, 2024 | USD 144.64 | 2.66% |
|
United States |
|
4 |
USD 25.57
|
Dec. 31, 2024 | USD 405.10 | 2.38% |
|
United States |
|
5 |
USD 22.77
|
Sept. 30, 2024 | USD 354.58 | 0.97% |
|
United States |
|
6 |
USD 22.29
|
Sept. 30, 2024 | USD 334.30 | 1.33% |
|
United States |
|
7 |
USD 19.69
|
Sept. 30, 2024 | USD 325.36 | 4.82% |
|
United States |
|
8 |
USD 19.29
|
Sept. 30, 2024 | USD 599.82 | 0.85% |
|
United States |
|
9 |
USD 16.52
|
Dec. 31, 2024 | USD 593.75 | -0.67% |
|
United States |
|
10 |
USD 15.50
|
Dec. 31, 2024 | USD 548.18 | 1.05% |
|
United States |
|
11 |
USD 15.04
|
Sept. 30, 2024 | USD 190.71 | 1.14% |
|
United States |
|
12 |
USD 14.34
|
Dec. 31, 2024 | USD 577.04 | 0.24% |
|
United States |
|
13 |
USD 11.42
|
Sept. 30, 2024 | USD 343.38 | -1.65% |
|
United States |
|
14 |
USD 11.36
|
Sept. 30, 2024 | USD 33.62 | -2.24% |
|
United States |
|
15 |
USD 11.29
|
Sept. 30, 2024 | USD 293.00 | -0.08% |
|
United States |
|
16 |
USD 11.07
|
Sept. 30, 2024 | USD 142.34 | -1.10% |
|
United States |
|
17 |
USD 10.48
|
Sept. 28, 2024 | USD 411.19 | -1.03% |
|
United States |
|
18 |
USD 9.27
|
Sept. 30, 2024 | USD 177.06 | 0.49% |
|
United States |
|
19 |
USD 9.14
|
Sept. 30, 2024 | USD 810.43 | -0.08% |
|
United States |
|
20 |
USD 8.10
|
Sept. 28, 2024 | USD 161.62 | -1.91% |
|
United States |
|
21 |
USD 7.98
|
Sept. 30, 2024 | USD 101.01 | -1.62% |
|
United States |
|
22 |
USD 7.81
|
Sept. 30, 2024 | USD 288.87 | 1.21% |
|
United States |
|
23 |
USD 7.77
|
Dec. 31, 2024 | USD 195.00 | -0.73% |
|
United States |
|
24 |
USD 7.76
|
Dec. 31, 2024 | USD 391.14 | -0.04% |
|
United States |
|
25 |
USD 7.71
|
Dec. 31, 2024 | USD 162.47 | -0.39% |
|
United States |
|
26 |
USD 7.62
|
Sept. 30, 2024 | USD 199.11 | -1.12% |
|
United States |
|
27 |
USD 7.51
|
Sept. 30, 2024 | USD 254.43 | 0.09% |
|
United States |
|
28 |
USD 6.93
|
Sept. 30, 2024 | USD 71.38 | -1.48% |
|
United States |
|
29 |
USD 6.74
|
Sept. 30, 2024 | USD 337.03 | -1.32% |
|
United States |
|
30 |
USD 6.22
|
Sept. 30, 2024 | USD 578.55 | 1.17% |
|
United States |
|
31 |
USD 6.05
|
Sept. 29, 2024 | USD 151.87 | -0.18% |
|
United States |
|
32 |
USD 6.01
|
Sept. 30, 2024 | USD 89.54 | -3.21% |
|
United States |
|
33 |
USD 5.94
|
Sept. 30, 2024 | USD 247.61 | 0.00% |
|
United States |
|
34 |
USD 5.88
|
Sept. 30, 2024 | USD 278.90 | 0.19% |
|
United States |
|
35 |
USD 5.86
|
Sept. 30, 2024 | USD 215.82 | -1.50% |
|
United States |
|
36 |
USD 5.76
|
Sept. 30, 2024 | USD 64.82 | 1.23% |
|
United States |
|
37 |
USD 5.36
|
Dec. 31, 2024 | USD 125.33 | 1.35% |
|
United States |
|
38 |
USD 5.28
|
Dec. 31, 2024 | USD 214.26 | -3.81% |
|
United States |
|
39 |
USD 5.26
|
Sept. 30, 2024 | USD 108.16 | -1.21% |
|
United States |
|
40 |
USD 5.17
|
Sept. 30, 2024 | USD 247.86 | -0.78% |
|
United States |
|
41 |
USD 5.04
|
Sept. 30, 2024 | USD 14.91 | -4.18% |
|
United States |
|
42 |
USD 5.03
|
Sept. 29, 2024 | USD 175.10 | -2.85% |
|
United States |
|
43 |
USD 5.00
|
Sept. 30, 2024 | USD 75.79 | 0.66% |
|
United States |
|
44 |
USD 4.77
|
Sept. 30, 2024 | USD 99.79 | 0.98% |
|
United States |
|
45 |
USD 4.71
|
Sept. 30, 2024 | USD 115.97 | 0.10% |
|
United States |
|
46 |
USD 4.52
|
Sept. 30, 2024 | USD 82.90 | 0.35% |
|
United States |
|
47 |
USD 4.42
|
Oct. 31, 2024 | USD 148.63 | -1.91% |
|
United States |
|
48 |
USD 4.37
|
Sept. 30, 2024 | USD 125.09 | -0.06% |
|
United States |
|
49 |
USD 4.27
|
Sept. 30, 2024 | USD 59.92 | -2.14% |
|
United States |
|
50 |
USD 4.21
|
Sept. 30, 2024 | USD 71.21 | -0.79% |
|
United States |
The Healthcare company in United States with the highest EPS (Diluted) is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at USD 119.47.
The Healthcare company in United States with the lowest EPS (Diluted) is Cartesian Therapeutics, Inc. (NasdaqGM: RNAC) at USD -47.77.
The top 10 Healthcare companies in United States by EPS (Diluted) are Inhibrx Biosciences, Inc., Regeneron Pharmaceuticals, Inc., Tenet Healthcare Corporation, Elevance Health Inc., United Therapeutics Corporation, HCA Healthcare, Inc., Molina Healthcare, Inc., McKesson Corporation, Thermo Fisher Scientific Inc. and UnitedHealth Group Incorporated.
The bottom 10 Healthcare companies in United States by EPS (Diluted) are Cartesian Therapeutics, Inc., Mesa Laboratories, Inc., Palisade Bio, Inc., Homology Medicines, Inc., Sonnet BioTherapeutics Holdings, Inc., QuidelOrtho Corporation, CalciMedica, Inc., Cidara Therapeutics, Inc., Madrigal Pharmaceuticals, Inc. and TransCode Therapeutics, Inc..